Id: | acc3070 |
Group: | 2sens |
Protein: | ACC |
Gene Symbol: | ACACA |
Protein Id: | Q13085 |
Protein Name: | ACACA_HUMAN |
PTM: | phosphorylation |
Site: | Ser79 |
Site Sequence: | GLALHIRSSMSGLHLVKQGRD |
Disease Category: | Cancer |
Disease: | Cancer |
Disease Subtype: | |
Disease Cellline: | "MCF-7,T98G,U87MG,PC-3,K-562,CEM T" |
Disease Info: | |
Drug: | AICAR |
Drug Info: | "AICAR is a drug that has been studied for its potential in various medical applications, including its effects on metabolism." |
Effect: | modulate |
Effect Info: | "AICAR activates AMPK, inhibits Akt phosphorylation, blocks the cell cycle, and inhibits the proliferation of tumor cells." |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 16176927 |
Sentence Index: | 16176927_4-5 |
Sentence: | "Anti-proliferative effect of AICAR is mediated through activated AMP-activated protein kinase (AMPK) as iodotubericidin and dominant-negative AMPK expression vector reversed the AICAR-mediated growth arrest. Moreover, constitutive active AMPK arrested the cells in S-phase by inducing the expression of p21, p27, and p53 proteins and inhibiting Akt phosphorylation, suggesting the involvement of AMPK." |
Sequence & Structure:
MDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAERPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLPAHTLLNTVDVELIYEGVKYVLKVTRQSPNSYVVIMNGSCVEVDVHRLSDGGLLLSYDGSSYTTYMKEEVDRYRITIGNKTCVFEKENDPSVMRSPSAGKLIQYIVEDGGHVFAGQCYAEIEVMKMVMTLTAVESGCIHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYVLDNLVNVMNGYCLPDPFFSSKVKDWVERLMKTLRDPSLPLLELQDIMTSVSGRIPPNVEKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFMNTQSIVQLVQRYRSGIRGHMKAVVMDLLRQYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFSHAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIASHLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSETSIFDVLPNFFYHSNQVVRMAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFMLPTSHPNRGNIPTLNRMSFSSNLNHYGMTHVASVSDVLLDNSFTPPCQRMGGMVSFRTFEDFVRIFDEVMGCFSDSPPQSPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAAMFREFTQQNKATLVDHGIRRLTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRHLEPALAFQLELNRMRNFDLTAIPCANHKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKEASFEYLQNEGERLLLEAMDELEVAFNNTNVRTDCNHIFLNFVPTVIMDPSKIEESVRSMVMRYGSRLWKLRVLQAELKINIRLTPTGKAIPIRLFLTNESGYYLDISLYKEVTDSRTAQIMFQAYGDKQGPLHGMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRILSTMDSPST
Select PDB:
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo intensity data of this site,
show all other sites!
ACACA-Ser114 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | 0.707 |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ACACA-Ser115 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.551 |
HGSC | 2.002 |
ccRCC | -0.121 |
GBM | |
HNSC | -0.422 |
LUAD | -0.657 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.252 |
ACACA-Ser117 | |
---|---|
Cancer | Intensity |
BRCA | -0.359 |
COAD | -0.987 |
HGSC | 2.245 |
ccRCC | -0.32 |
GBM | 0.34 |
HNSC | -0.76 |
LUAD | -0.983 |
LUSC | -0.091 |
non_ccRCC | 1.36 |
PDAC | 0.042 |
UCEC | -0.486 |
ACACA-Ser1296 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ACACA-Ser133 | |
---|---|
Cancer | Intensity |
BRCA | -1.393 |
COAD | -0.649 |
HGSC | |
ccRCC | -0.373 |
GBM | 0.932 |
HNSC | 0.59 |
LUAD | -0.815 |
LUSC | -0.572 |
non_ccRCC | 1.729 |
PDAC | |
UCEC | 0.552 |
ACACA-Ser60 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.861 |
HGSC | -1.112 |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.829 |
LUSC | |
non_ccRCC | -0.578 |
PDAC | |
UCEC |
ACACA-Ser62 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.324 |
HGSC | 0.699 |
ccRCC | |
GBM | 0.054 |
HNSC | 1.783 |
LUAD | -0.918 |
LUSC | |
non_ccRCC | -0.125 |
PDAC | |
UCEC | -1.169 |
ACACA-Ser66 | |
---|---|
Cancer | Intensity |
BRCA | -0.591 |
COAD | -0.164 |
HGSC | -1.093 |
ccRCC | 0.441 |
GBM | -0.153 |
HNSC | 1.181 |
LUAD | -0.386 |
LUSC | 1.028 |
non_ccRCC | 1.804 |
PDAC | -1.365 |
UCEC | -0.701 |
ACACA-Ser872 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
ACACA-Thr647 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.199 |
HGSC | |
ccRCC | 1.378 |
GBM | -1.421 |
HNSC | |
LUAD | -0.379 |
LUSC | -0.549 |
non_ccRCC | |
PDAC | |
UCEC | 0.773 |
ACACA-Thr870 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.